Abstract
IntroductionMental disorders represent the second cause of years lived with disability worldwide. Suicide mortality has been targeted as a key public health concern by the WHO. Smartphone technology provides a huge potential to develop massive and fast surveys. Given the vast cultural diversity of Mexico and its abrupt orography, smartphone-based resources are invaluable in order to adequately manage resources, services and preventive measures in the population. The objective of this study is to conduct a universal suicide risk screening in a rural area of Mexico, measuring also other mental health outcomes such as depression, anxiety and alcohol and substance use disorders.Methods and analysisA population-based cross-sectional study with a temporary sampling space of 9 months will be performed between September 2019 and June 2020. We expect to recruit a large percentage of the target population (at least 70%) in a short-term survey of Milpa Alta Delegation, which accounts for 137 927 inhabitants in a territorial extension of 288 km2.They will be recruited via an institutional call and a massive public campaign to fill in an online questionnaire through mobile-assisted or computer-assisted web app. This questionnaire will include data on general health, validated questionnaires including Well-being Index 5, Patient Health Questionnaire-9, Generalized Anxiety Disorder Scale 2, Alcohol Use Disorders Identification Test, selected questions of the Drug Abuse Screening Test and Columbia-Suicide Severity Rating Scales and Diagnostic and statistical manual of mental disorders (DSM-5) questions about self-harm.We will take into account information regarding time to mobile app response and geo-spatial location, and aggregated data on social, demographical and environmental variables. Traditional regression modelling, multilevel mixed methods and data-driven machine learning approaches will be used to test hypotheses regarding suicide risk factors at the individual and the population level.Ethics and disseminationEthical approval (002/2019) was granted by the Ethics Review Board of the Hospital Psiquiátrico Yucatán, Yucatán (Mexico). This protocol has been registered in ClinicalTrials.gov. The starting date of the study is 3 September 2019. Results will serve for the planning and healthcare of groups with greater mental health needs and will be disseminated via publications in peer-reviewed journal and presented at relevant mental health conferences.Trial registration numberNCT04067063.
Reference60 articles.
1. Institute for Health Metrics and Evaluation . Global burden of disease study 2017 (GBD 2017) incidence, prevalence, and years lived with disability 1990-2017, 2019. Available: http://ghdx.healthdata.org/gbd-2017 [Accessed 2 Aug 2019].
2. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
3. Institute for Health Metrics and Evaluation . GBD 2017. GBD comp. - viz hub, 2019. Available: https://vizhub.healthdata.org/gbd-compare/ [Accessed 3 Aug 2019].
4. World Health Organisation . Suicide. heal. top, 2019. Available: https://www.who.int/westernpacific/health-topics/suicide [Accessed 7 Aug 2019].
5. United Nations . Global indicator framework for the sustainable development goals and targets of the 2030 agenda for sustainable development. SDG Indic, 2019. Available: https://unstats.un.org/sdgs/indicators/indicators-list/ [Accessed 27 Jun 2019].
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献